DIabetic Retinopathy Candesartan Trials.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,850

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

February 29, 2008

Study Completion Date

April 30, 2008

Conditions
Type 1 Diabetes
Interventions
DRUG

candesartan

32 mg oral tablet

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

AstraZeneca

INDUSTRY